Articles From: Incyte Reports Second-Quarter 2013 Financial Results; Increases Revenue Guidance; Updates Shareholders on Key Clinical Programs to CME Group Inc. Reports Strong Second-Quarter 2013 Financial Results


Incyte Corporation (Nasdaq: INCY) today reported second-quarter 2013 financial results, including revenue from Jakafi ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF). The Company also increased its 2013 net product revenue guidance to a range of $220 million to $230 million, a change from the previous range of $210 million to $225 million; highlighted additional positive data recently presented at key scientific meetings for its lead JAK1 and JAK2 inhibitors, Jakafi and baricitinib, and its novel immunotherapy, INCB24360, an oral IDO1 inhibitor; and described progress for several other clinical programs, including additional potential indications for Jakafi.
Sign-up for Incyte Reports Second-Quarter 2013 Financial Results; Increases Revenue Guidance; Updates Shareholders on Key Clinical Programs investment picks
2013/8/1
Spectrum Pharmaceuticals (NasdaqGS:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a teleconference and webcast with management to discuss the second quarter 2013 financial results, provide an update on the Company's business, and discuss expectations for the future.
Sign-up for Spectrum Pharmaceuticals Announces Second Quarter 2013 Financial Results Teleconference and Webcast investment picks
Steve Madden (Nasdaq: SHOO) , a leading designer and marketer of fashion footwear and accessories for women, men and children, today announced financial results for the second quarter ended June 30, 2013.
Sign-up for Steve Madden Announces Second Quarter 2013 Results investment picks
2013/8/1
ALBANY, N.Y., Aug.
Sign-up for AngioDynamics to Present at 33rd Annual Canaccord Growth Conference investment picks
Lumos Networks Corp.
Sign-up for Lumos Networks Corp. Reports Second Quarter 2013 Financial Results investment picks
2013/8/1
DANVERS, Mass., Aug.
Sign-up for Abiomed Announces First Quarter Fiscal 2014 Revenue of $42.7 Million, Up 10% Over Prior Year investment picks
Companies to Join Forces to Broaden Market for Comprehensive Prenatal Analyses SAN DIEGO and IRVINE, Calif.
Sign-up for Sequenom And CombiMatrix Announce Collaboration Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing investment picks
2013/8/1
Second Quarter Highlights: Revenue of $101.9 million, flat year-over-year and up 3% sequentially Gross margin of 26.1% compared to 26.2% year ago and 25.4% in Q1 Operating income of $6.7 million; as adjusted operating income of $9.7 million, down 20% year-over-year, up 31% sequentially Net income of $1.2 million; as adjusted net income of $3.5 million, down 30% year-over-year, up 52% sequentially Generated strong cash from operations of $8.3 million Debt reduced $7.9 million WARSAW, Ind., Aug.
Sign-up for Symmetry Medical Reports Second Quarter 2013 Financial Results investment picks
2013/8/1
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Reports Second Quarter 2013 Results investment picks
Cost-reduction initiatives on track; Debt-free balance sheet; $9 million of shares repurchased CLEVELAND , Aug.
Sign-up for OM Group Announces Second Quarter 2013 Financial Results investment picks
2013/8/1
- Submission of European Marketing Authorization Application Planned for this Quarter - SEATTLE , Aug.
Sign-up for Omeros Submits New Drug Application to U.S. FDA for OMS302 investment picks
2013/8/1
—Texas Advertising Agency Signs Multi-Year StationView Essentials Contract For Rentrak's Local Currency— PORTLAND, Ore.
Sign-up for Griffin Wink Signs Contract With Rentrak For Local TV Ratings Information investment picks
2013/8/1
Conn's, Inc. (NASDAQ:CONN) , a specialty retailer of home appliances, furniture, mattresses and consumer electronics and provider of consumer credit, announced today that the Company will be presenting at the 33 rd  Annual Canaccord Genuity Growth Conference in Boston, Massachusetts on Wednesday, August 14, 2013 at 8:30 a.m. Eastern Time.
Sign-up for Conn’s, Inc. Management to Present at the Canaccord Genuity 33rd Annual Growth Conference investment picks
TORONTO , Aug.
Sign-up for Mood Media Q2 2013 Results Conference Call Scheduled for August 8, 2013 investment picks
2013/8/1
PARIS , Aug.
Sign-up for Sanofi Q2 2013: Last Quarter with Significant Negative Impact from the Patent Cliff investment picks
2013/8/1
VILLA GUARDIA (COMO), Italy, Aug.
Sign-up for Gentium to Report First Half 2013 Financial Results investment picks
2013/8/1
hhgregg, Inc. (NYSE: HGG) :     Three Months Ended June 30, (unaudited, amounts in thousands, except share and per share data) 2013     2012 Net sales $ 524,922 $ 489,856 Net sales % increase 7.2 % 13.5 % Comparable store sales % increase (decrease) (1) 0.8 % (5.1 )% Gross profit as a % of net sales 29.5
Sign-up for hhgregg Announces First Fiscal Quarter Operating Results investment picks
2013/8/1
- Company confirms full year sales and profit guidance, expects strong second half - - Company to host conference call at 8:30 a.m. ET on August 1, 2013 - EAST RUTHERFORD, N.J. , Aug.
Sign-up for Cambrex Reports Second Quarter 2013 Financial Results investment picks
2013/8/1
ATK Reports First Quarter Book-to-Bill Ratio of 1.3 ATK Increases FY14 Full-Year Sales, EPS and Free Cash Flow Guidance, Reflecting Improved Performance and the Acquisition of Caliber Company ARLINGTON, Va.
Sign-up for ATK Reports First Quarter Operating Results investment picks
PITTSBURGH , Aug.
Sign-up for CONSOL Energy Reports Partial Structural Failure at Bailey Preparation Plant investment picks
NEWARK, N.Y., Aug.
Sign-up for Ultralife Corporation Reports Second Quarter Results investment picks
http://media.marketwire.com/attachments/201304/60218_west.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1039149&ProfileId=051205&sourceType=1 EXTON, PA --
Sign-up for West Announces Second Quarter 2013 Results investment picks
2013/8/1
http://media.marketwire.com/attachments/201304/60218_west.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1039050&ProfileId=051205&sourceType=1 EXTON, PA --
Sign-up for West Announces Stock Split and Raises Quarterly Dividend investment picks
2013/8/1
- 2Q13 Total Net Revenues Increased by 29% vs.
Sign-up for Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results investment picks
MANCHESTER, Conn., Aug.
Sign-up for Lydall Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2013 investment picks
2013/8/1
ITT Corporation (NYSE: ITT) today reported that second-quarter 2013 total revenue grew by 9 percent to $609 million with 2 percent organic growth (defined as total revenue excluding foreign exchange, recent acquisitions and divestitures). ITT’s total revenue results reflect gains in key geographies, including 13 percent growth in Western Europe and 12 percent growth in emerging markets.
Sign-up for ITT Announces Solid Results for 2013 Second Quarter investment picks
2013/8/1
HOLLISTON, Mass., Aug.
Sign-up for HBIO Reports Second Quarter 2013 Results investment picks
CHICAGO , Aug.
Sign-up for CME Group Inc. Reports Strong Second-Quarter 2013 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Incyte Reports Second-Quarter 2013 Financial Results; Increases Revenue Guidance; Updates Shareholders on Key Clinical Programs to CME Group Inc. Reports Strong Second-Quarter 2013 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity